Eli Lilly (LLY) Tax Rate (2009 - 2026)
Eli Lilly (LLY) posted Tax Rate of 16.43% for Q1 2026, down 16.61% quarter-over-quarter from 19.7% in Q4 2025, and down 374.0% year-on-year from 6.0% in Q1 2025.
Eli Lilly (LLY) Tax Rate (2009 - 2026) Analysis & Trends
Eli Lilly (LLY) has reported Tax Rate for 18 consecutive years, with 16.43% the latest figure, recorded in Q1 2026.
- Tax Rate for Q1 2026 came in at 16.43%, down 374.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 18.79% (up 45.0% YoY), and the FY2025 annual result was 19.79%, up 330.0% from the prior year.
- Tax Rate was 16.43% for Q1 2026 at Eli Lilly, down from 19.7% in the prior quarter.
- Over five years, Tax Rate peaked at 113.44% in Q3 2023 and troughed at 7.27% in Q3 2022.
- Average Tax Rate over 5 years is 21.34%, with a median of 15.59% recorded in 2023.
- Year-over-year, Tax Rate soared 10617 bps in 2023 and sank 7452 bps in 2024.
- Over 5 years, Tax Rate stood at 7.57% in 2022, then jumped by 68 bps to 12.71% in 2023, then fell by 2 bps to 12.47% in 2024, then soared by 58 bps to 19.7% in 2025, then slipped by 17 bps to 16.43% in 2026.
- Per Business Quant data, the three most recent Tax Rate figures were 16.43% in Q1 2026, 19.7% in Q4 2025, and 22.81% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 16.43% |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 12.60% |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 32.92% |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 78.72% |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -20.26% |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 12.72% |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 21.67% |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 14.54% |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | 15.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.43 |
| Mar 31, 2026 | 16.43 |
| Dec 31, 2025 | 19.70 |
| Dec 31, 2025 | 19.70 |
| Sep 30, 2025 | 22.81 |
| Sep 30, 2025 | 22.81 |
| Jun 30, 2025 | 16.47 |
| Jun 30, 2025 | 16.47 |
| Mar 31, 2025 | 20.17 |
| Mar 31, 2025 | 20.17 |
| Dec 31, 2024 | 12.47 |
| Dec 31, 2024 | 12.47 |
| Sep 30, 2024 | 38.91 |
| Sep 30, 2024 | 38.91 |
| Jun 30, 2024 | 15.64 |
| Jun 30, 2024 | 15.64 |
| Mar 31, 2024 | 11.56 |
| Mar 31, 2024 | 11.56 |
| Dec 31, 2023 | 12.71 |
| Dec 31, 2023 | 12.71 |